Market Overview:
The global cotinine screening devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of smoking and rising awareness about the health hazards associated with smoking. In addition, the growing demand for cotinine screening devices in clinical testing and workplace testing applications is also contributing to the growth of this market. However, factors such as high cost of these devices and lack of skilled professionals are restraining the growth of this market. On the basis of type, the global cotinine screening devices market can be segmented into cassettes, strips, and others. The cassettes segment is expected to account for a major share in this market owing to their ease-of-use and accuracy. On the basis of application, this market can be divided into clinical testing, workplace testing, and others segments. Clinical testing accounted for a major share in 2017 owing to rising demand for early diagnosis and treatment options for various diseases caused by smoking tobacco products.
Product Definition:
Cotinine Screening Devices are used to detect the presence of cotinine in a person's system. Cotinine is a chemical that is produced when nicotine is metabolized by the body. Cotinine screening devices are important because they can be used to determine whether or not someone has been smoking cigarettes or using other tobacco products.
Cotinine Screening Cassettes:
It is formed in the body when nicotine enters cells and then converted to an inactive form. Cotinine can be detected in urine by using a urinary cotinine test or through hair samples if cotinine levels are high enough.
Cotinine Screening Strips:
Cotinine is an organic compound that is found in the urine of humans and animals. It is a nicotine-based alkaloid, also known as 4-aminobutylene. Cotinine can be extracted from the leaves, stems, roots or bark of certain plants including cassava and tobacco.
Application Insights:
The clinical testing segment dominated the global cotinine screening devices market in 2017. This can be attributed to the rising prevalence of nicotine dependence and abuse among a large population, which, in turn, is resulting in an increasing number of tests being conducted for detecting cotinine levels.
Cotinine is primarily metabolized into nortriptyline and then excreted through urine as well as breath. Thus, it has been used extensively for the detection of recent tobacco consumption or use by others. However, this method has been proved to be less reliable than other screening methods due to various factors such as metabolism rate; therefore other options are preferred over it while conducting drug tests on employees or patients seeking medical care.
The workplace testing segment is expected to exhibit lucrative growth during the forecast period owing to growing awareness about substance abuse among organizations regarding their employees' usage habits especially with regard to drugs like marijuana and alcohol which have become legal across several U.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of cotinine screening devices, and increasing number of clinical trials. The U.S., which is a major contributor to North America’s dominance in this space, has one of the highest rates for tobacco consumption across all regions with more than 330 million cigarettes consumed every year as per World Bank data released in 2016.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to factors such as growing prevalence for cancer among smokers coupled with government initiatives and increasing awareness about early detection through various programs organized by public health organizations such as WHO & PAHO or industry-sponsored events held annually throughout Asia Pacific region that focus on raising awareness about smoking cessation products.
Growth Factors:
- Increasing demand for cotinine screening devices due to growing awareness about the health hazards of smoking and passive smoking.
- Rising prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders due to tobacco smoke exposure.
- Growing number of anti-smoking campaigns and regulations aimed at reducing tobacco consumption.
- Technological advancements in cotinine screening devices that make them more sensitive and accurate.
- increasing demand for point-of-care testing (POCT) devices owing to their ease of use and fast turnaround time
Scope Of The Report
Report Attributes
Report Details
Report Title
Cotinine Screening Devices Market Research Report
By Type
Cotinine Screening Cassettes, Cotinine Screening Strips, Others
By Application
Clinical Testing, Workplace Testing, Others
By Companies
Abbott, Sinocare Inc, Calbiotech Inc, Jant Pharmacal, AlcoPro, Germaine Laboratories, Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Cotinine Screening Devices Market Report Segments:
The global Cotinine Screening Devices market is segmented on the basis of:
Types
Cotinine Screening Cassettes, Cotinine Screening Strips, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Testing, Workplace Testing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Sinocare Inc
- Calbiotech Inc
- Jant Pharmacal
- AlcoPro
- Germaine Laboratories
- Mossman Associates
- Nano-Ditech Corp
- LifeSign LLC
- ALFA Scientific
- Abbott
Highlights of The Cotinine Screening Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cotinine Screening Cassettes
- Cotinine Screening Strips
- Others
- By Application:
- Clinical Testing
- Workplace Testing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cotinine Screening Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cotinine screening devices are used to measure the level of cotinine in a person's blood. Cotinine is a by-product of nicotine metabolism and can be found in the blood after smoking cigarettes.
Some of the major players in the cotinine screening devices market are Abbott, Sinocare Inc, Calbiotech Inc, Jant Pharmacal, AlcoPro, Germaine Laboratories, Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Abbott.
The cotinine screening devices market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cotinine Screening Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cotinine Screening Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cotinine Screening Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cotinine Screening Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cotinine Screening Devices Market Size & Forecast, 2018-2028
4.5.1 Cotinine Screening Devices Market Size and Y-o-Y Growth
4.5.2 Cotinine Screening Devices Market Absolute $ Opportunity
Chapter 5 Global Cotinine Screening Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cotinine Screening Devices Market Size Forecast by Type
5.2.1 Cotinine Screening Cassettes
5.2.2 Cotinine Screening Strips
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cotinine Screening Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cotinine Screening Devices Market Size Forecast by Applications
6.2.1 Clinical Testing
6.2.2 Workplace Testing
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cotinine Screening Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cotinine Screening Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cotinine Screening Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cotinine Screening Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cotinine Screening Devices Market Size Forecast by Type
9.6.1 Cotinine Screening Cassettes
9.6.2 Cotinine Screening Strips
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cotinine Screening Devices Market Size Forecast by Applications
9.10.1 Clinical Testing
9.10.2 Workplace Testing
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cotinine Screening Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cotinine Screening Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cotinine Screening Devices Market Size Forecast by Type
10.6.1 Cotinine Screening Cassettes
10.6.2 Cotinine Screening Strips
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cotinine Screening Devices Market Size Forecast by Applications
10.10.1 Clinical Testing
10.10.2 Workplace Testing
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cotinine Screening Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cotinine Screening Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cotinine Screening Devices Market Size Forecast by Type
11.6.1 Cotinine Screening Cassettes
11.6.2 Cotinine Screening Strips
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cotinine Screening Devices Market Size Forecast by Applications
11.10.1 Clinical Testing
11.10.2 Workplace Testing
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cotinine Screening Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cotinine Screening Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cotinine Screening Devices Market Size Forecast by Type
12.6.1 Cotinine Screening Cassettes
12.6.2 Cotinine Screening Strips
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cotinine Screening Devices Market Size Forecast by Applications
12.10.1 Clinical Testing
12.10.2 Workplace Testing
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cotinine Screening Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cotinine Screening Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cotinine Screening Devices Market Size Forecast by Type
13.6.1 Cotinine Screening Cassettes
13.6.2 Cotinine Screening Strips
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cotinine Screening Devices Market Size Forecast by Applications
13.10.1 Clinical Testing
13.10.2 Workplace Testing
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cotinine Screening Devices Market: Competitive Dashboard
14.2 Global Cotinine Screening Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Sinocare Inc
14.3.3 Calbiotech Inc
14.3.4 Jant Pharmacal
14.3.5 AlcoPro
14.3.6 Germaine Laboratories
14.3.7 Mossman Associates
14.3.8 Nano-Ditech Corp
14.3.9 LifeSign LLC
14.3.10 ALFA Scientific
14.3.11 Abbott
